Premium
BENDAMUSTINE AS PART OF CONDITIONING REGIMEN FOR AUTOLOGOUS STEM‐CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE LYMPHOMAS: FINAL ANALYSIS OF A PHASE 2 STUDY FROM GELTAMO
Author(s) -
Martín A.,
Redondo A.M.,
Valcárcel D.,
González A.P.,
SuárezLledó M.,
Bello J.L.,
Canales M.,
Gayoso J.,
Conde E.,
Jarque I.,
Campo R.,
Arranz R.,
Terol M.J.,
Rifón J.,
Rodríguez M.J.,
Ramírez M.J.,
Castro N.,
Sánchez A.,
LópezJiménez J.,
Briones J.,
López A.,
Palomera L.,
Caballero D.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_54
Subject(s) - bendamustine , medicine , regimen , melphalan , transplantation , etoposide , salvage therapy , autologous stem cell transplantation , follicular lymphoma , surgery , gastroenterology , phases of clinical research , diffuse large b cell lymphoma , cytarabine , lymphoma , chemotherapy , rituximab